These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38043438)

  • 1. Provider communication contributes to colorectal cancer screening intention through improving screening outcome expectancies and perceived behavioral control.
    Zhu X; Squiers L; Helmueller L; Madson G; Southwell BG; Alam S; Finney Rutten LJ
    Soc Sci Med; 2024 Jan; 340():116397. PubMed ID: 38043438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Provider Communication and Colorectal Cancer Screening Completion Using Multi-target Stool DNA Testing.
    Zhu X; Squiers L; Madson G; Helmueller L; Southwell BG; Alam S; Finney Rutten LJ
    J Cancer Educ; 2024 Jul; ():. PubMed ID: 39031303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
    Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
    J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
    [No Abstract]   [Full Text] [Related]  

  • 4. Barriers to utilization of three colorectal cancer screening options - Data from a national survey.
    Zhu X; Parks PD; Weiser E; Jacobson DJ; Limburg PJ; Finney Rutten LJ
    Prev Med Rep; 2021 Dec; 24():101508. PubMed ID: 34401220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort.
    Miller-Wilson LA; Rutten LJF; Van Thomme J; Ozbay AB; Limburg PJ
    Int J Colorectal Dis; 2021 Nov; 36(11):2471-2480. PubMed ID: 34019124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial validation of a self-report questionnaire based on the Theoretical Domains Framework: determinants of clinician adoption of a novel colorectal cancer screening strategy.
    Zhu X; Lee MK; Weiser E; Griffin JM; Limburg PJ; Finney Rutten LJ
    Implement Sci Commun; 2021 Oct; 2(1):119. PubMed ID: 34666841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
    Berger BM; Schroy PC; Dinh TA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
    Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
    Berger BM; Parton MA; Levin B
    Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening.
    Kisiel JB; Fendrick AM; Ebner DW; Ozbay AB; Vahdat V; Estes C; Limburg PJ
    J Med Econ; 2024; 27(1):746-753. PubMed ID: 38686394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study.
    Imperiale TF; Lavin PT; Marti TN; Jakubowski D; Itzkowitz SH; May FP; Limburg PJ; Sweetser S; Daghestani A; Berger BM
    Cancer Prev Res (Phila); 2023 Feb; 16(2):89-97. PubMed ID: 36205504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.
    Pickhardt PJ; Correale L; Hassan C
    AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
    [No Abstract]   [Full Text] [Related]  

  • 15. Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing.
    Voss JK; Ebner DW; Burger KN; Mahoney DW; Devens ME; Lowrie KL; Kisiel JB
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2399-2406. PubMed ID: 36621751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening: The role of MT-sDNA testing.
    Mollman BJ
    JAAPA; 2023 Aug; 36(8):15-20. PubMed ID: 37399452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Provider Characteristics Associated With Colorectal Cancer Screening Preferences and Use.
    Finney Rutten LJ; Parks PD; Weiser E; Fan C; Jacobson DJ; Jenkins GD; Zhu X; Griffin JM; Limburg PJ
    Mayo Clin Proc; 2022 Jan; 97(1):101-109. PubMed ID: 34920895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate Ordering of Multitarget Stool DNA Tests for Colon Cancer Screening.
    Ahn AB; Kulhari S; Rhee J; Cooper G
    J Am Board Fam Med; 2024; 37(2):328-331. PubMed ID: 38740492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
    Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
    Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.